COMMUNIQUÉS West-GlobeNewswire

Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
04/12/2025
Praxis confirms plans to submit the essential tremor NDA for ulixacaltamide in early 2026 BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical [...]
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
04/12/2025
SAN DIEGO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced the commencement of a [...]
GATC Health to Host Virtual KOL Event to Discuss Derisq™ AI Report: Predictive, Detailed Risk Assessment of Drug Candidates, on December 10, 2025
04/12/2025
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host a virtual key [...]
Latest Legal Anabolic Steroid Alternatives for Bodybuilding 2026: Natural Steroids for Muscle Building & Cutting Fat Introduced by CrazyBulk
04/12/2025
Legal Anabolic Steroid Alternatives for Bodybuilding from CrazyBulk in 2026: Best Selling Natural Steroids for Muscle Building and Cutting Fat. New York City, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) -- In 2026, there is [...]
SAFE - Résultats annuels 2024 - Mise à disposition du rapport annuel 2024
04/12/2025
Résultats annuels 2024 Mise à disposition du rapport annuel 2024 Fleurieux-sur-l’Arbresle – France – 4 décembre 2025 – 20h - Safe (FR001400ZU25 – ALSAF) (la « Société ») annonce ses résultats annuels et avoir mis à la [...]
Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
04/12/2025
Kensington, MD, USA and Munich/Martinsried, Germany, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small [...]
Zhittya Genesis Medicine Announces Initial Results Suggesting Potential Reversal of Type 2 Diabetes in Human Study
04/12/2025
Groundbreaking discovery points to a potential disease-reversing treatment for Type-2 Diabetes LAS VEGAS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine today announced promising initial results from a human [...]
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
04/12/2025
WASHINGTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s response to its first-ever [...]
Mental Health Experts Available for a Variety of Mental Health Topics
04/12/2025
Spokespeople from Talkspace Available for Interviews, Quotes and Rapid-Response Commentary New York, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) -- As newsrooms continue covering the growing mental health crisis, especially [...]
Foundation Health and Amazon Pharmacy Collaborate to Bring Real-Time Prescription Price Transparency to Patients
04/12/2025
API Integration Improves Medication Access and Empowers Patients with Expanded Fulfillment Options SAN FRANCISCO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Foundation Health, a healthcare technology company that delivers AI- [...]
Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference
04/12/2025
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). [...]
Coloplast A/S - Decisions at the Annual General Meeting 2025
04/12/2025
Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2024/25 was approved. Distribution of year-end dividend of [...]
Human Appeal’s Pot of Gold Film Comes to Amazon Prime Video
04/12/2025
BayView Entertainment Brings Groundbreaking Film to Global Streaming Audiences MISSION VIEJO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Pot of Gold , the award winning powerful independent documentary set in the [...]
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
04/12/2025
ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 [...]
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
04/12/2025
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new biomarker data identifying a molecular signature that predicts [...]
McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN
04/12/2025
BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region has equipped its Emergency Department treatment rooms with MEDI+SIGN Digital Whiteboards and Door Displays to enhance the patient experience and [...]
USOSM Secures Partnership with Northern Virginia Oral, Maxillofacial & Implant Surgery
04/12/2025
IRVING, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has formalized a new [...]
BeautyHealth Releases Third Annual Skintuition Report
04/12/2025
Latest volume reveals how shifting consumer preferences are redefining modern aesthetics LONG BEACH, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial [...]
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
04/12/2025
Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz ® over treatment area of 240 cm 2 Completion of this study marks a key milestone towards a planned [...]

Pages